X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
male (23) 23
adult (19) 19
pharmacology & pharmacy (16) 16
middle aged (12) 12
female (10) 10
blood pressure - drug effects (9) 9
adolescent (7) 7
index medicus (7) 7
double-blind method (6) 6
animals (5) 5
area under curve (5) 5
article (5) 5
child (5) 5
dose-response relationship, drug (5) 5
drug interactions (5) 5
heart rate - drug effects (5) 5
adhd (4) 4
adolescents (4) 4
attention-deficit/hyperactivity disorder (4) 4
blood-pressure (4) 4
children (4) 4
deficit hyperactivity disorder (4) 4
imidazoles - pharmacology (4) 4
pharmacokinetics (4) 4
psychiatry (4) 4
thromboxane b2 - blood (4) 4
cross-over studies (3) 3
fluoroquinolones (3) 3
half-life (3) 3
hemodynamics - drug effects (3) 3
hypertension (3) 3
indomethacin - pharmacology (3) 3
rats (3) 3
thromboxane-a synthase - antagonists & inhibitors (3) 3
treatment (3) 3
treatment outcome (3) 3
administration, oral (2) 2
adrenocorticotropic hormone - blood (2) 2
angiotensin-converting enzyme (2) 2
angiotensin-converting enzyme inhibitors - pharmacokinetics (2) 2
anti-infective agents - pharmacology (2) 2
antidepressant (2) 2
antidepressive agents, second-generation - pharmacokinetics (2) 2
antidepressive agents, second-generation - pharmacology (2) 2
arachidonic acid (2) 2
aryl hydrocarbon hydroxylases - genetics (2) 2
attention deficit disorder (2) 2
attention deficit disorder with hyperactivity - physiopathology (2) 2
attention deficit disorder with hyperactivity - therapy (2) 2
care and treatment (2) 2
clinical neurology (2) 2
cognitive remediation (2) 2
cognitive training (2) 2
coronary circulation - drug effects (2) 2
cytochrome p-450 cyp2c19 (2) 2
dogs (2) 2
drug administration schedule (2) 2
drug synergism (2) 2
drug-interactions (2) 2
efficacy (2) 2
electrocardiography (2) 2
electrocardiography - drug effects (2) 2
endocrinology & metabolism (2) 2
fluoxetine (2) 2
follow-up (2) 2
hiv (2) 2
hiv protease inhibitors - pharmacokinetics (2) 2
infusions, intravenous (2) 2
infusions, parenteral (2) 2
injections, intravenous (2) 2
intervention (2) 2
irbesartan (2) 2
kinetics (2) 2
medication (2) 2
memory, short-term - physiology (2) 2
metabolic clearance rate (2) 2
metabolites (2) 2
nelfinavir (2) 2
nelfinavir - pharmacokinetics (2) 2
neurosciences (2) 2
neutral endopeptidase inhibition (2) 2
oxidoreductases - antagonists & inhibitors (2) 2
pharmacodynamics (2) 2
piperazines (2) 2
polymorphism, genetic (2) 2
protease inhibitor nelfinavir (2) 2
psychology, developmental (2) 2
pyridines - pharmacokinetics (2) 2
pyridines - pharmacology (2) 2
radioimmunoassay (2) 2
reference values (2) 2
serum (2) 2
thiazepines - pharmacokinetics (2) 2
thiazepines - pharmacology (2) 2
thromboxane a (2) 2
triazoles - pharmacokinetics (2) 2
triazoles - pharmacology (2) 2
vasopeptidase inhibitor (2) 2
working memory (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Parke, E and Hart, J and Baldock, D and Barchard, K and Etcoff, L and Allen, D and Stolberg, P and Nardi, N and Cohen, J and Jones, W and Loe, S and Delgaty, L and Tan, A and Bunner, M and Goodman, G and Kim, W and Nolty, A and Marion, S and Davis, A and Finch, W and Piehl, J and Moss, L and Nogin, R and Dean, R and Davis, J and Lindstrom, W and Poon, M and Fonseca, F and Bure-Reyes, A and Stewart, J and Golden, C and Fields, K and Hill, B and Corley, E and Russ, K and Boettcher, A and Musso, M and Rohling, M and Rowden, A and Downing, K and Benners, M and Miller, D and Maricle, D and Dugbartey, T and Anum, A and Anderson, J and Daniel, M and Hoskins, L and Gillis, K and Khen, S and Carter, K and Ayers, C and Neeland, I and Cullum, M and Weiner, M and Rossetti, H and Buddin, W and Mahal, S and Schroeder, R and Baade, L and Macaluso, M and Phelps, K and Evans, C and Clark, J and Vickery, C and Chow, J and Stokic, D and Watson, S and Odom, R and Thompson, J and Noggle, C and Kane, C and Kecala, N and Lane, E and Raymond, M and Woods, S and Iudicello, J and Dawson, M and Ghias, A and Ellis, R and Grant, I and Weber, E and Atkinson, J and Uderman, J and Miele, A and Rabinovitz, B and Schaffer, S and Burns, W and Olivier, T and Shapiro, E and Schleicher-Dilks, S and Andrews, P and Fontanetta, R and Demsky, Y and Burns, K and Sakamoto, M and Loftis, J and Huckans, M and Westervelt, H and Long, J and ... and PREDICT-HD Investigators and Coordinators of the Huntington Study Group
Archives of Clinical Neuropsychology, ISSN 0887-6177, 09/2013, Volume 28, Issue 6, pp. 518 - 626
Journal Article
Archives of Clinical Neuropsychology, ISSN 0887-6177, 01/2013, Volume 28, Issue 6, pp. 15 - 15
Objective: We present two detailed cases referred for neuropsychological evaluations following extensive cerebellar vascular injury due to arteriovenous... 
Journal Article
Child and Adolescent Psychiatric Clinics of North America, ISSN 1056-4993, 07/2013, Volume 22, Issue 3, pp. 457 - 477
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 06/2000, Volume 20, Issue 6P2, pp. 49S - 58S
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 02/1999, Volume 65, Issue 2, pp. 132 - 132
Clinical Pharmacology & Therapeutics (1999) 65, 132–132; doi: 
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 12/2001, Volume 41, Issue 12, pp. 1351 - 1358
A 21-day, open-label, multisite, dose escalation study comprising three demographic groups (children, adolescents, and adults) was performed to determine the... 
Journal Article
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 07/1999, Volume 39, Issue 7, pp. 685 - 694
Avitriptan, a selective 5-HT1-like receptor agonist, is an effective compound for the treatment of migraine headaches with a prolonged duration of response. A... 
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 03/1999, Volume 17, Issue 3, pp. 225 - 231
Objective: This study evaluated the effect of advanced age on the single-dose and steady-state pharmacokinetics of the angiotensin converting enzyme inhibitor... 
Fosinopril, pharmacokinetics | Hydrochlorothiazide, pharmacokinetics | Clinical-pharmacokinetics | Antihypertensives, pharmacokinetics | Elderly | Age-differences | PHARMACOLOGY & PHARMACY | SERUM | HYPERTENSION | COMBINATION THERAPY | AGE
Journal Article